Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-May 2025. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5454836014 | Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique (observable entity) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5457255013 | Ratio of ERBB2 (erb-b2 receptor tyrosine kinase 2) to CEP17 (chromosome 17 centromere signals) per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5457419015 | Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique (observable entity) | Is a | Neoplasm observable | true | Inferred relationship | Some | ||
| Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique (observable entity) | Inheres in | Malignant neoplasm (morphologic abnormality) | true | Inferred relationship | Some | 1 | |
| Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique (observable entity) | Property (attribute) | Ratio | true | Inferred relationship | Some | 1 | |
| Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique (observable entity) | Scale type (attribute) | Quantitative value | true | Inferred relationship | Some | 1 | |
| Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique (observable entity) | Direct site (attribute) | Tissue specimen obtained by excision (specimen) | true | Inferred relationship | Some | 1 | |
| Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique (observable entity) | Inherent location (attribute) | Breast structure | true | Inferred relationship | Some | 1 | |
| Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique (observable entity) | Technique | In situ hybridisation technique | true | Inferred relationship | Some | 1 | |
| Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique (observable entity) | Time aspect (attribute) | Single point in time | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR